feminized seeds
In a survey looking at physicians’ choice of drugs to treat wasting, the first line choice of 80 percent of the care providers was megestrol with dronabinol being used by 54 percent of feminized marijuana seeds. Dronabinol was also the second line choice of most providers. Problems that have been identified with dronabinol are that patients feel “too stoned”; are unable to titrate their dose properly; note delayed onset of effect, prolonged duration of effect, or problems with malabsorption; and “not the same feeling as smoked marijuana.”